MedTrace Logo

Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

NCT02481011 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22111

Last updated 2018-08-28

No results posted yet for this study

Summary

The true incidence and risks of intracranial hemorrhage (ICH) in patients on various antithrombotic treatments remain unknown. Here a nationwide study is conducted to investigate the risk for and incidence rates of ICH in users and non-users of various oral antithrombotic drugs in Norway between 2008 through 2014.

Hopefully, this study will contribute to a more responsible prescription pattern of antithrombotic medications.

Conditions

  • Intracranial Hemorrhages
  • Stroke

Interventions

DRUG

antithrombotic drugs

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Sasha Gulati, md phd · Norwegian University of Science and Technology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-01-01
Completion
2016-01-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02481011 on ClinicalTrials.gov